Revolutionizing Sample Preparation: Cornell Startup Quantera Analytical
In the realm of high-tech science, breakthroughs often hinge on the minutest details, especially before the experiment even begins. Before a lab can detect contaminants in drinking water, identify performance-enhancing drugs in an athlete's blood, or measure volatile compounds in food, scientists must first extract target chemicals from a complex mixture. This crucial step, known as sample preparation, is a bottleneck in analytical science, often slow, resource-intensive, and wasteful.
Now, a Cornell-born startup, Quantera Analytical, is poised to revolutionize this process. Their technology is deceptively simple yet powerful: a modular, cartridge-based system that replaces traditional, time-consuming, and solvent-heavy workflows with rigid, reusable sample collectors. These cartridges can absorb vapors above a sample or dip directly into liquids like blood, juice, or plant extracts.
This innovation enables scientists to process dozens of samples simultaneously, significantly speeding up the process, reducing waste, and eliminating the need for costly centralized labs. Terry Bates, Ph.D. '23, founder and analytical food chemist at Quantera, emphasizes the accessibility aspect, stating, 'Small growers and labs often face disadvantages due to the high costs of testing.'
Quantera's technology has caught the attention of industry leaders, including Bruker, a German scientific instrument manufacturer. Bruker's collaboration with Quantera involves using a state-of-the-art mass spectrometer to validate the new system, showcasing their interest in faster, more flexible testing platforms. Bates, who previously worked at Bruker, understands the potential impact of this technology, having previously worked on a similar innovation during his graduate studies.
The startup has already filed patents for its core extraction device and a range of accessories, including cartridge holders, gaskets, and storage systems designed for high-throughput lab and field use. Traditional sample preparation methods, such as solid-phase microextraction, are finicky, expensive, and difficult to scale. In contrast, Quantera's rigid planar cartridges, arranged in standard well-plate formats, offer durability and eliminate solvent waste.
The implications of this technology extend beyond the lab. It can accelerate food and beverage testing, environmental monitoring after spills, and open new possibilities for decentralized analysis, where testing occurs on-site rather than being shipped to central facilities. Bates highlights the versatility of their approach, stating, 'We've demonstrated its effectiveness across various compounds, from food quality indicators to markers of fungal contamination.'
However, any new testing platform must undergo rigorous validation before clinical or regulatory use, and scaling production hardware is a significant challenge. Yet, Cornell's entrepreneurial support system, including business incubators and alumni investors, provides Quantera with a strong launchpad. This support is crucial for refining the business plan, connecting with investors, and navigating product validation and intellectual property complexities.
For New York state, this story represents a broader trend: how research universities are translating deep science into real-world innovation. Bates emphasizes the startup's commitment to stewardship, stating, 'Our goal goes beyond technology; it's about making analytical workflows more efficient, sustainable, useful, and accessible, enabling the scientific community to push the boundaries of discovery.'
